Trial intelligence / Profile preview

Dose exploration and safety of fospropofol disodium for anesthesia in gastroenteroscopy

ChiCTR2200060626Phase 4Recruiting

Sponsor
First Affiliated Hospital of Soochow University
Start
May 2022
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of fospropofol disodium in Esophagogastroduodenoscopy (EGD) (6 arms), sponsored by First Affiliated Hospital of Soochow University. Primary endpoints: Onset time, Duration of procedure and 2 more. Started May 2022; status: recruiting.

02

Drugs

fospropofol disodium
03

Conditions

Esophagogastroduodenoscopy (EGD)

Beyond the preview

Go deeper on ChiCTR2200060626.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200060626.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call